Edition:
United States

Eagle Pharmaceuticals Inc (EGRX.OQ)

EGRX.OQ on NASDAQ Stock Exchange Global Market

43.90USD
7 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$43.90
Open
$47.23
Day's High
$47.35
Day's Low
$43.88
Volume
86,771
Avg. Vol
102,724
52-wk High
$85.66
52-wk Low
$43.88

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 1.18 December 10 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 3 3
(3) HOLD 3 3 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.40 2.40 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 54.17 58.30 49.90 55.10
Quarter Ending Mar-19 3 55.60 58.70 52.90 --
Year Ending Dec-18 5 211.43 215.50 207.20 214.60
Year Ending Dec-19 5 231.63 250.54 218.60 247.57
Earnings (per share)
Quarter Ending Dec-18 4 1.18 1.34 0.85 1.18
Quarter Ending Mar-19 2 1.05 1.16 0.94 --
Year Ending Dec-18 4 3.83 3.99 3.51 4.37
Year Ending Dec-19 5 4.61 5.45 3.74 5.04

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 53.43 51.34 2.10 3.92
Quarter Ending Jun-18 51.23 59.30 8.07 15.74
Quarter Ending Mar-18 48.88 46.63 2.25 4.60
Quarter Ending Dec-17 52.91 46.78 6.12 11.58
Quarter Ending Sep-17 51.86 63.02 11.16 21.53
Earnings (per share)
Quarter Ending Sep-18 0.98 1.18 0.20 20.41
Quarter Ending Jun-18 0.80 0.95 0.15 18.45
Quarter Ending Mar-18 0.69 0.53 0.16 22.63
Quarter Ending Dec-17 1.00 1.00 0.00 0.50
Quarter Ending Sep-17 0.80 1.22 0.42 52.98

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 54.17 54.17 55.43 60.94 55.10
Quarter Ending Mar-19 55.60 55.60 55.60 57.20 --
Year Ending Dec-18 211.43 211.43 213.23 222.28 214.60
Year Ending Dec-19 231.63 231.63 235.77 253.40 247.57
Earnings (per share)
Quarter Ending Dec-18 1.18 1.18 1.23 1.33 1.18
Quarter Ending Mar-19 1.05 1.05 1.05 1.18 --
Year Ending Dec-18 3.83 3.83 3.85 3.49 4.37
Year Ending Dec-19 4.61 4.61 4.50 4.40 5.04

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 1
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 1
Year Ending Dec-19 0 0 0 1
Earnings
Quarter Ending Dec-18 0 0 0 1
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 1
Year Ending Dec-19 0 0 1 0